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The aim of any neonatal screening program is to detect affected neonates and provide early intervention for preventable and correctable congenital conditions. 
Congenital hypothyroidism (CH) being one of the major 
correctable disease, if detected earlier can help in improving 
neurodevelopmental outcome of child and ultimately, leading 
to completely normal life for him [1-3]. Hypothyroidism occurs 
due to decreased production of thyroid hormones or a defect in 
thyroid hormone transport/or receptor activity. Causes of CH 
are thyroid digenesis, dyshormonogenesis, and transient and 
hypothalamic-pituitary defects. Early diagnosis and adequate 
treatment of neonatal hypothyroidism from 1st week of life result 
in normal growth and development of the affected child [4,5]. 
Most of the infants with CH are asymptomatic at birth because 
of transplacental passage of moderate amounts (1/3rd) of maternal 
T4. Transplacental passage of thyroid-stimulating hormone 
(TSH) does not occur [6]. Due to low level of serum T4 and 
concomitantly high levels of TSH in these newborns, it is possible 
to screen neonates to detect CH.
Heel prick TSH assay has been found to be more sensitive 
than cord blood TSH assay in identifying CH [7]. Neonatal 
screening for CH is a routine in most of the developed 
countries. Incidence of CH in developed countries is in the 
range of 1:3600-1:5000 newborns [8] while in India, it was 
reported to be as high as 2.1/1000 [9]. District-wise surveys 
conducted by Indian Council of Medical Research/Director 
General of Health Services in Jharkhand state found that 8 of the 
9 districts surveyed are endemic for iodine deficiency disorder. 
Consumption of adequately iodized salt was only 64.2% in 
Jharkhand [10]. We could not find any study on the prevalence 
of CH in children in Jharkhand; therefore, the current study 
was planned to fill this gap. Current random sample survey 
and screening for the presence of CH was carried out among 
children born in tertiary care hospitals of Jharkhand. Pregnant 
women from all over state report for delivery in these hospitals 
and other nearby hospitals.
METHODS
In this cross-sectional study was conducted over a period of 1 year 
after getting approval from the Institutional Ethics Committee. 
Written consent from parents of the newborns was taken before 
sampling. Babies were included in the study using sampling 
by convenience. In the current study, hospitals were selected 
around 20 km radius of Rajendra Institute of Medical Sciences 
to facilitate logistics. The nursing staffs, laboratory technicians, 
and residents were trained for the collection and storage of blood 
samples in a proper manner in newborns from 2nd to 7th day of life. 
The various screening programs recommend collection of blood 
sample between 2 and 7 days of life. The best time for screening 
ABSTRACT
Objective: To screen newborns for congenital hypothyroidism by time resolved fluoroimmunoassay (TRFIA) (TRFIA meter by 
Perkin Elmer). Methods: Participants were randomly selected from the Department of Paediatrics/Obstetrics and Gynaecology, 
Rajendra Institute of Medical Sciences and Maternity Hospitals around 20 km of Rajendra Institute of Medical Sciences, Ranchi. 
Blood samples were obtained by heel prick for thyroid-stimulating hormone (TSH) estimation from newborns selected from above-
mentioned hospitals. Samples were collected from 3rd day of life to 7th day of life on a filter paper card and analyzed by TRFIA-
based method. Results: 60% of the newborns were male and 40% were female among 150 newborns selected for study. Out of 
them, 65.33% were term, 28% were pre-term, and 6.67% were post-term. 92% newborns had TSH level <10 mIU/L, 8% had TSH 
between 10 and 20 mIU/L and none had TSH value >20 mIU/L. Conclusion: The prevalence of borderline TSH assay was 80/1000 
newborns, which is significant. Screening studies for such conditions need larger sample size, stronger logistics to cover a larger 
area.
Key words: Congenital hypothyroidism, Newborn, Thyroid-stimulating hormone, Time resolved fluoroimmunoassay
Vol 4 | Issue 4 | Oct - Dec 2017 Indian J Child Health 543
Prasad et al. Neonatal screening for congenital hypothyroidism
of neonates is 3-5 days of life when the post-natal physiological 
TSH surge subsides.
Blood was collected by heel prick method from the most 
medial or lateral portion of the plantar surface of the heel after 
taking universal precaution. The blood was collected on filter 
paper by gently touching it against the large blood drop and in one 
step a sufficient quantity of blood was allowed to soak through 
and completely fill three circles of about half inch diameter. 
Blood was applied to only one side of the filter paper. The samples 
collected were transported to processing laboratory.
Analysis of samples was done in the laboratory of Gen-next 
at Ranchi. The samples were tested for the determination of TSH 
level by time-resolved fluorometry-based dissociation-enhanced 
lanthanide fluorescent assay (DELFIA). The technology is based 
on the use of lanthanide chelate labels with unique fluorescence 
properties. The usefulness of a time-resolved fluoroimmunoassay 
(TRFIA) kit (DELFIA neonatal TSH) for the determination 
of thyrotropin TSH in dried blood spots in routine newborn 
screening for CH had been evaluated [11]. The new method 
fulfills the criteria for precision and sensitivity of a screening 
assay. Following cutoff values of TSH were considered: TSH 
<10 mIU/L - normal, TSH between 10 and 20 mIU/L - Borderline 
cases and TSH >20 mIU/L - hypothyroid.
RESULTS
A total of 150 newborns were included in the study. The mean birth 
weight was 2500 g (1160-3400 g) and mean gestational age was 
38.3 weeks (28-43 weeks). Total 104 newborns were delivered 
vaginally and 46 were delivered by lower segment cesarean 
section (LSCS). In this study, there were 42 pre-term, 98 term 
and 10 post-term neonates. The gestational age of newborns was 
determined according to the obstetric history, antenatal ultrasound, 
and new Ballard scoring system. There were 14 (9.33%) very low 
birth weight babies, 82 (54.67%) low birth weight and 54 (36%) 
normal birth weight babies. 70 newborns had uneventful post-
natal period, 36 newborns had perinatal asphyxia, 16 had neonatal 
jaundice, 20 had early onset sepsis, 6 had late onset sepsis, and 
2 newborns had dehydration fever. National Neonatal Perinatal 
Database (2002-2003) definitions for above-mentioned neonatal 
morbidities have been used for the classification.
In this study, 40% of the sample was taken at 3rd day of life, 
32% on 2nd day, 16% on 4th day, and 5.33% samples were taken on 
5th day of life. Table 1 show that 92% of the newborns had TSH 
level <10 mIU/L and 8% had TSH between 10 and 20 mIU/L 
while no newborn had TSH >20 mIU/L. TSH level ranged from 
1.16 to 15.74 mIU/L with a mean value of 5.94±2.9 mIU/L.
DISCUSSION
The prevalence of borderline TSH assay cases was 
80/1000 newborns. We did not find any confirmed case of CH. 
8% of the newborns in our series had values between 10 and 
20 mIU/L. This is the group which needs further evaluation to 
confirm the thyroxine deficiency either acquired or congenital. 
Mean TSH of newborns born vaginally were similar to mean TSH 
of newborns born by LSCS. We also did not find any significant 
difference in TSH level between pre-term, term, and post-term 
newborns. The average prevalence of CH worldwide is about 1 
in 4000 (range of 1:3600-1:5000) newborns. Data on incidence 
of CH in India are emerging and these data point toward much 
higher burden of the disease in India.
Desai et al. in 1987 screened 12,407 newborns for CH 
using cord blood TSH measurements and found the incidence 
of 1:264 [12]. Sanghvi et al. reported an incidence of 2.1 in 
1000 [9]. Newborn screening conducted in Hyderabad reported a 
prevalence of 1 in 1700 live births [13]. A study from Chandigarh 
reported prevalence of 1:3400 [14]. Medda et al. in a population 
case-control study found that there was high risk for CH in 
low birth weight and high birth weight newborns. They also 
reported that female gender, twin, additional birth defects, and 
post-term were significantly associated with permanent CH [15]. 
Gopalakrishnan et al. found significantly higher TSH level in 
males, low birth weight and vaginally delivered newborns [16]. 
We did not find such correlation probably due to small sample 
size. Some researchers have suggested lower TSH cutoff level 
for screening as a cutoff level of 20 mIU/ml would miss as 
much as 45% newborns with CH including cases of thyroid 
digenesis [17]. A recent study from Bengaluru used same method 
for TSH assessment (TRFIA - DELFIA) and lower cutoff value of 
12 mIU/ml reporting an incidence of 1:825 for CH [18].
Limitation of study were small sample size and inability 
to conduct follow-up and do further confirmatory tests for the 
borderline cases. Collection of samples from other centers and 
motivating staffs to collect samples were the major hurdles 
in this study. Collection of neonatal blood sample demands 
strong operational and logistic efforts with a team approach. 
Our study highlighted that this project needs to be undertaken 
in areas like Jharkhand with a large tribal population and known 
iodine deficiency. Large state program requires large resources. 
However, this experience of small project gave us immense 
guidance and confidence to start program in Jharkhand whenever 
Table 1: Value of TSH among newborns (n=150) measured by 
heel – prick on 2nd-7th day of life
Mean±SD 5.94±2.9 mIU/L
Median range 5.23 (1.16-15.74) mIU/L
Mean TSH in newborns delivered 
vaginally
5.90±2.7 mIU/L
Mean TSH in newborns delivered by 
LSCS
5.63±3.28 mIU/L
Mean TSH in pre-term 5.92 mIU/L
Mean TSH in term 5.90 mIU/L
Mean TSH in post-term 5.48 mIU/L
Number of newborns with TSH values
<10 mIU/L 138 (92)
10-20 mIU/L 8 (8)
>20 mIU/L 0 (0)
TSH: Thyroid-stimulating hormone, LSCS: Lower segment cesarean section, 
SD: Standard deviation
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government or any large non-governmental organizations is 
willing to undertake the responsibility.
CONCLUSION
Lower cutoff for TSH may have more sensitivity for detecting CH. 
Large-scale population-based study on CH is needed in Iodine 
deficiency prone state like Jharkhand.
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